Antitumour and antiangiogenic effects of IDN 5390, a novel C-seco taxane, in a paclitaxel-resistant human ovarian tumour xenograft

por Petrangolini, G, Cassinelli, G, Pratesi, G, Tortoreto, M, Favini, E, Supino, R, Lanzi, C, Belluco, S, Zunino, F
Publicado 2004

IDN 5390: an oral taxane candidate for protracted treatment schedules

por Pratesi, G, Laccabue, D, Lanzi, C, Cassinelli, G, Supino, R, Zucchetti, M, Frapolli, R, D'Incalci, M, Bombardelli, E, Morazzoni, P, Riva, A, Zunino, F
Publicado 2003